Welcome to Stem Cells for Safer Medicines
Stem Cells for Safer Medicines is a public-private collaboration whose objective is:
To enable the creation of a bank of stem cells, open protocols and standardised systems in stem cell technology that will enable consistent differentiaition of stem cells into stable homogenous populations of particular cell types, with physiologically relevant phenotypes suitable for toxicology testing in high throughput platforms.
The collaboration will draw upon scientific expertise within pharmaceutical companies - especiall in relation to saftey assessment of ne medicines - academic stem cell expertsin the UK and seek engagement with third parties including biotechnology companies.
Stem Cells for Safer Medicines is therefore interested in the potential of differentiating human stem cells into normal human cells such as those in the live (hepatocytes) for use in the early, high throughput, toxicology screening of potential new medicines. However, substansive scientific hurdle remain that are best tackled by a public-private collaboration.
